| RS2517350221 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517351044 |
SON
|
Health Risk |
Pathogenic |
— |
| RS2517351378 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517354241 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517358316 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517360088 |
ADA2
|
Health Risk |
Likely pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2517360414 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2517361483 |
ADA2
|
Health Risk |
Pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2517362747 |
SON
|
Health Risk |
Pathogenic |
SON-related disorder, SON-related disorder |
| RS2517364357 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517364388 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517365943 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517366003 |
SON
|
Health Risk |
Likely pathogenic |
SON-related disorder, SON-related disorder |
| RS2517366385 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517366478 |
CBS
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, HYPERHOMOCYSTEINEMIA |
| RS2517366644 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517367249 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517367397 |
SYNJ1
|
Health Risk |
Pathogenic |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS2517368270 |
SON
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2517368419 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517368476 |
MCM3AP
|
Health Risk |
Likely pathogenic |
— |
| RS2517368826 |
SYNJ1
|
Health Risk |
Likely pathogenic |
Early-onset Parkinson disease 20, Developmental and epileptic encephalopathy |
| RS2517368907 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517370239 |
SON
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2517371094 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517373694 |
TSPEAR
|
Health Risk |
Pathogenic |
— |
| RS2517373699 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517374413 |
TSPEAR
|
Health Risk |
Pathogenic |
— |
| RS2517375631 |
MCM3AP
|
Health Risk |
Likely pathogenic |
— |
| RS2517377176 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2517377446 |
COL18A1
|
Health Risk |
Pathogenic |
— |
| RS2517379776 |
ADA2
|
Health Risk |
Likely pathogenic |
Deficiency of adenosine deaminase 2, Deficiency of adenosine deaminase 2 |
| RS2517381422 |
SON
|
Health Risk |
Pathogenic |
— |
| RS2517382043 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517386716 |
MCM3AP
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2517387184 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517389781 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517390727 |
MCM3AP
|
Health Risk |
Conflicting classifications of pathogenicity |
Peripheral neuropathy, autosomal recessive |
| RS2517391041 |
SON
|
Health Risk |
Likely pathogenic |
— |
| RS2517391196 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517392381 |
SON
|
Health Risk |
Conflicting classifications of pathogenicity |
ZTTK syndrome, ZTTK syndrome |
| RS2517394724 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517395064 |
SON
|
Health Risk |
Pathogenic |
— |
| RS2517395250 |
TSPEAR
|
Health Risk |
Likely pathogenic |
TSPEAR-related disorder, TSPEAR-related disorder |
| RS2517395485 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517395819 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517399568 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517399972 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517400216 |
CBS
|
Health Risk |
Pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517400347 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517401007 |
MCM3AP
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2517401659 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517403114 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517403206 |
SON
|
Health Risk |
Pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517411603 |
CBS
|
Health Risk |
Pathogenic/Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517412566 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517412611 |
SON
|
Health Risk |
Likely pathogenic |
ZTTK syndrome, ZTTK syndrome |
| RS2517413033 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517413127 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517418480 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517422081 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517422365 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517422915 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517423269 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517423296 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517423483 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517424159 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517424268 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517424319 |
HLCS
|
Health Risk |
Pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517424327 |
HLCS
|
Health Risk |
Pathogenic/Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS2517424483 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517425105 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517425362 |
CBS
|
Health Risk |
Likely pathogenic |
Homocystinuria, Classic homocystinuria |
| RS2517428448 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517429476 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517429781 |
CBS
|
Health Risk |
Likely pathogenic |
Homocystinuria, Homocystinuria |
| RS2517434063 |
MCM3AP
|
Health Risk |
Likely pathogenic |
— |
| RS2517435640 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517436177 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517436265 |
RUNX1
|
Health Risk |
Likely pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517436400 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517436554 |
CBS
|
Health Risk |
Likely pathogenic |
Classic homocystinuria, Classic homocystinuria |
| RS2517436589 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517436753 |
CBS
|
Health Risk |
Likely pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517436960 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517437126 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517437166 |
CBS
|
Health Risk |
Pathogenic |
HYPERHOMOCYSTEINEMIA, THROMBOTIC |
| RS2517437278 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517437634 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517438095 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517438116 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517438242 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517438518 |
MCM3AP
|
Health Risk |
Pathogenic |
Peripheral neuropathy, autosomal recessive |
| RS2517439109 |
MCM3AP
|
Health Risk |
Pathogenic |
— |
| RS2517439152 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517439168 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517439221 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematologic cancer predisposition syndrome, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517439367 |
MCM3AP
|
Health Risk |
Pathogenic |
Peripheral neuropathy, autosomal recessive |
| RS2517439655 |
RUNX1
|
Health Risk |
Pathogenic |
Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1, Hereditary thrombocytopenia and hematologic cancer predisposition syndrome |
| RS2517439683 |
MCM3AP
|
Health Risk |
Pathogenic/Likely pathogenic |
— |